The enzyme acetylcholine esterase (AChE) is the key enzyme in the hydrolysis of the neurotransmitter acetylcholine and is also the target of most of the clinically used agents for the treatment of PD (Wang et al. 2020). The gene discussed is ACHE; the disease is Parkinson disease.